Great West Life Assurance CO Krystal Biotech, Inc. Transaction History
Great West Life Assurance CO
- $57.4 Billion
- Q3 2024
A detailed history of Great West Life Assurance CO transactions in Krystal Biotech, Inc. stock. As of the latest transaction made, Great West Life Assurance CO holds 26,776 shares of KRYS stock, worth $5.01 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
26,776
Previous 27,373
2.18%
Holding current value
$5.01 Million
Previous $5.03 Million
3.2%
% of portfolio
0.01%
Previous 0.01%
Shares
13 transactions
Others Institutions Holding KRYS
# of Institutions
287Shares Held
24.9MCall Options Held
270KPut Options Held
177K-
Black Rock Inc. New York, NY3.95MShares$739 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.85MShares$534 Million0.01% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.43MShares$456 Million6.1% of portfolio
-
State Street Corp Boston, MA1.33MShares$250 Million0.01% of portfolio
-
Redmile Group, LLC San Francisco, CA1.02MShares$191 Million12.22% of portfolio
About Krystal Biotech, Inc.
- Ticker KRYS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,664,300
- Market Cap $4.8B
- Description
- Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...